|
|
|
Court hears testimony on whether Assange was spied on
Legal World News |
2020/07/25 08:58
|
Spain’s National Court heard testimony Monday in an investigation into whether a Spanish company was hired to spy on Julian Assange during the seven years the WikiLeaks founder spent in the Ecuadorean Embassy in London.
The court is investigating whether David Morales, a Spaniard, and his Undercover Global S.L. security agency invaded the privacy of Assange and his visitors at the embassy by secretly recording their meetings. The intelligence that Morales’ company collected is suspected of being handed over to third parties, according to court papers.
Among those set to face the court's questions Monday were prominent Spanish lawyer Baltasar Garzon, who is part of Assange’s legal team; former Ecuadorean consul in London Fidel Narvaez; and Stella Morris, a legal adviser and Assange’s partner, who revealed earlier this year that she had two children with him while he lived in the embassy. Staff of the Spanish security company are due to testify on Tuesday.
Assange, whose lawyers filed a complaint at the court to trigger the investigation, is in a British prison after being removed from the embassy last year. He is fighting extradition to the United States, where he faces espionage charges over the activities of WikiLeaks.
The court is conducting an investigation, begun last year, before deciding whether there is evidence of wrongdoing that warrants a trial.
Undercover Global, also known as UC Global, was hired by Ecuador’s government to provide security at the Ecuadorean embassy in London between 2015 and 2018. Its main task was to secure the property’s perimeter, including the deployment of security staff, due to Assange’s presence inside, court papers say. |
|
|
|
|
|
|
California court upholds verdict in Monsanto cancer case
Legal Information |
2020/07/22 10:53
|
A California appeals court on Monday upheld a groundbreaking verdict that Monsanto’s widely used weed killer caused cancer in a school groundskeeper but the panel also slashed the damage award from $78.5 million to $21.5 million.
The 1st District Court of Appeal said there was evidence to support a California jury’s 2018 decision that “Monsanto acted with a conscious disregard for public safety,” but it reduced the damages to Dewayne Johnson of Vallejo because state law doesn’t allow damages for reduced life expectancy, the San Francisco Chronicle reported.
The original San Francisco Superior Court jury found that St. Louis-based Monsanto had purposely ignored warnings and evidence that glyphosate, the active ingredient in its popular Roundup and Ranger Pro products, causes cancer.
Johnson, then 46, alleged that his non-Hodgkin’s lymphoma was caused by his years of spraying Ranger Pro on school grounds in Benicia.
Jurors awarded Johnson $289.2 million but a judge later reduced the punitive damages, knocking down the total to $78.5 million.
In further reducing the total award, the appellate court ruled 3-0 that state law entitled Johnson only to compensation for future harm he was “reasonably certain” to suffer. He had been given only two to three years to live.
R. Brent Wisner, a lawyer for Johnson, said the ruling was an overall victory but the court shouldn’t have reduced the damage award.
“This effectively rewards a defendant for killing a plaintiff, as opposed to just injuring him,” Wisner told the Chronicle.
Bayer AG, the German corporation that owns Monsanto, called the reduction “a step in the right direction” but said the appellate panel should have thrown out the verdict and said it may appeal to the California Supreme Court. |
|
|
|
|
|
|
Justice Ginsburg says cancer has returned, but won’t retire
State Law Issues |
2020/07/19 08:25
|
Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.
The 87-year-old Ginsburg, who has had four earlier bouts with cancer including pancreatic cancer last year, said her treatment so far has succeeded in reducing lesions on her liver and she will continue chemotherapy sessions every two weeks “to keep my cancer at bay.”
“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.
Ginsburg, who was appointed by President Bill Clinton in 1993, is the senior liberal justice on a court that leans conservative by a 5-4 margin. Her departure before the election could give President Donald Trump the chance to shift the court further to the right.
Ginsburg’s history with cancer goes back more than 20 years. In addition to being treated without surgery for a tumor on her pancreas last year, she also underwent surgery for colorectal cancer in 1999, pancreatic cancer in 2009 and lung cancer in December 2018.
Dr. Alan Venook, a pancreatic cancer specialist at the University of California, San Francisco, who is not involved in Ginsburg’s care, said that “clearly, she’s got incurable disease now” because of the spread to her liver.
On average, patients with advanced pancreatic cancer live about a year, but the fact that her disease took so long to recur from her initial pancreatic cancer surgery in 2009 and previous treatments “suggests that it’s not been growing rapidly,” he said.
“She’s above average in many ways.” and has done remarkably well with all her treatments so far, Venook said. “There’s no reason to think she would die imminently.”
Asked earlier this week about a possible opening on the court before the election, White House chief of staff Mark Meadows said the president would act quickly if any opening were to arise. Meadows commented after news that Ginsburg had left the hospital after receiving treatment for an infection, which she said Friday was unrelated to the cancer.
“I can’t imagine if he had a vacancy on the Supreme Court that he would not very quickly make the appointment and look for the Senate to take quick action,” Meadows said, adding that he didn’t want any comment to be seen as wishing Ginsburg “anything but the very best.”
Senate Majority Leader Mitch McConnell, R-Ky., has said that if there were to be a vacancy on the court during this year’s election cycle, the Republican-controlled Senate would likely confirm a nominee selected by Trump.
Ginsburg said she was disclosing her cancer treatment now because she is satisfied “that my treatment course is now clear.”
Venook said the chemotherapy drug Ginsburg said she is getting, gemcitabine, is one that’s often used. Immunotherapy, which Ginsburg’s statement said she tried unsuccessfully, has not worked well for pancreatic cancer, Venook said.
Ginsburg said a medical scan in February revealed growths on her liver and she began chemotherapy in May.
“My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease,” she said. “I am tolerating chemotherapy well and am encouraged by the success of my current treatment.” |
|
|
|
|
|
|
Trump tax ruling a new front in defamation suits against him
Legal Information |
2020/07/17 08:26
|
When the U.S. Supreme Court decided this month that the presidency isn’t a shield against a New York prosecutor’s criminal investigation, the justices didn’t say whether the same goes for civil suits against the president in state courts.
That has quickly become a question in two closely watched defamation lawsuits filed by women who say President Donald Trump smeared them while denying their sexual assault allegations.
Lawyers for the women, E. Jean Carroll and Summer Zervos, are now trying to persuade New York courts that the U.S. Supreme Court’s ruling strengthens their arguments for letting the suits go forward. Trump’s attorneys are contending just the opposite.
The dispute comes with one of the cases now before New York’s highest court, which is weighing whether a sitting president is constitutionally protected from being sued in state courts.
“The answer is no” under the U.S. Supreme Court’s reasoning, Zervos attorneys Beth Wilkinson and Moira Penza wrote in a letter Friday to the top-level state Court of Appeals.
|
|
|
|
|
|
Law Firm News RSS Feed
